These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
|
|
Delaware
|
|
04-2833935
|
|
State or other jurisdiction of
incorporation or organization
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
200 John Hancock Rd., Taunton, MA
|
|
02780-1042
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
|
Large accelerated filer
|
|
¨
|
Accelerated filer
|
|
x
|
|
Non-accelerated filer
|
|
¨
|
Smaller reporting company
|
|
¨
|
|
Class
|
Outstanding as of November 2, 2012
|
|
|
Common Stock, par value $.01
|
66,295,412
|
|
|
|
|
|
|
|
|
Page
No.
|
|
|
||
|
Item 1.
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
|
|
|
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 2.
|
||
|
Item 5.
|
||
|
Item 6.
|
||
|
|
||
|
Item 1:
|
Condensed Consolidated Financial Statements (Unaudited)
|
|
|
September 29,
2012 |
|
December 31,
2011 |
||||
|
ASSETS
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and equivalents
|
$
|
25,263,239
|
|
|
$
|
43,095,163
|
|
|
Marketable debt securities, at fair value
|
69,273,996
|
|
|
62,323,387
|
|
||
|
Accounts receivable, net of allowance of $454,000 and $513,000 in 2012 and 2011, respectively
|
12,293,195
|
|
|
16,510,851
|
|
||
|
Accounts receivable from unconsolidated affiliates
|
2,072,892
|
|
|
1,340,788
|
|
||
|
Unbilled receivables
|
587,652
|
|
|
36,115
|
|
||
|
Inventory
|
19,684,989
|
|
|
20,468,512
|
|
||
|
Prepaid taxes
|
878,320
|
|
|
667,759
|
|
||
|
Prepaid expenses and other current assets
|
1,052,351
|
|
|
1,294,368
|
|
||
|
Total current assets
|
131,106,634
|
|
|
145,736,943
|
|
||
|
Property, plant and equipment, net
|
33,710,208
|
|
|
32,369,441
|
|
||
|
Deferred tax assets, net
|
3,472,437
|
|
|
4,201,627
|
|
||
|
Goodwill
|
1,140,787
|
|
|
1,664,457
|
|
||
|
Intangible assets, net
|
1,829,151
|
|
|
1,953,660
|
|
||
|
Other assets
|
9,287,486
|
|
|
7,946,087
|
|
||
|
Total assets
|
$
|
180,546,703
|
|
|
$
|
193,872,215
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
9,503,243
|
|
|
$
|
12,384,869
|
|
|
Accrued payroll and expenses
|
3,037,011
|
|
|
4,182,505
|
|
||
|
Accrued warranty
|
1,015,000
|
|
|
1,318,000
|
|
||
|
Billings in excess of revenue earned
|
2,214,889
|
|
|
2,467,461
|
|
||
|
Other accrued liabilities
|
4,925,003
|
|
|
2,126,954
|
|
||
|
Total current liabilities
|
20,695,146
|
|
|
22,479,789
|
|
||
|
Asset retirement obligations
|
1,144,773
|
|
|
1,295,670
|
|
||
|
Commitments and contingencies
|
|
|
|
||||
|
Stockholders’ equity:
|
|
|
|
||||
|
Preferred stock, par value $.01 per share: authorized, 3,000 shares; none issued
|
—
|
|
|
—
|
|
||
|
Common stock, par value $.01 per share: authorized, 120,000,000 shares; issued 76,156,551 shares in 2012 and 76,123,940 shares in 2011; outstanding 63,414,292 shares in 2012 and 64,361,491 shares in 2011
|
732,754
|
|
|
732,263
|
|
||
|
Additional paid-in capital
|
318,515,179
|
|
|
315,710,160
|
|
||
|
Treasury stock (9,861,139 and 8,864,767 shares in 2012 and 2011, respectively, at cost)
|
(34,450,978
|
)
|
|
(30,995,449
|
)
|
||
|
Accumulated other comprehensive income
|
6,380,602
|
|
|
4,146,024
|
|
||
|
Accumulated deficit
|
(139,132,141
|
)
|
|
(124,631,665
|
)
|
||
|
Total Kopin Corporation stockholders’ equity
|
152,045,416
|
|
|
164,961,333
|
|
||
|
Noncontrolling interest
|
6,661,368
|
|
|
5,135,423
|
|
||
|
Total stockholders’ equity
|
158,706,784
|
|
|
170,096,756
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
180,546,703
|
|
|
$
|
193,872,215
|
|
|
|
Three Months Ended
|
|
Nine months ended
|
||||||||||||
|
|
September 29,
2012 |
|
September 24,
2011 |
|
September 29,
2012 |
|
September 24,
2011 |
||||||||
|
Revenues:
|
|
|
|
|
|
|
|
||||||||
|
Net product revenues
|
$
|
21,013,668
|
|
|
$
|
28,512,486
|
|
|
$
|
67,449,979
|
|
|
$
|
91,031,145
|
|
|
Research and development revenues
|
926,690
|
|
|
1,053,964
|
|
|
2,585,900
|
|
|
4,900,754
|
|
||||
|
|
21,940,358
|
|
|
29,566,450
|
|
|
70,035,879
|
|
|
95,931,899
|
|
||||
|
Expenses:
|
|
|
|
|
|
|
|
||||||||
|
Cost of product revenues
|
15,834,791
|
|
|
19,753,495
|
|
|
49,714,995
|
|
|
60,813,990
|
|
||||
|
Research and development
|
6,399,053
|
|
|
6,381,089
|
|
|
16,519,193
|
|
|
19,905,398
|
|
||||
|
Selling, general and administration
|
5,466,289
|
|
|
4,351,794
|
|
|
15,591,101
|
|
|
13,494,589
|
|
||||
|
Impairment of goodwill
|
—
|
|
|
—
|
|
|
1,704,770
|
|
|
—
|
|
||||
|
|
27,700,133
|
|
|
30,486,378
|
|
|
83,530,059
|
|
|
94,213,977
|
|
||||
|
(Loss) income from operations
|
(5,759,775
|
)
|
|
(919,928
|
)
|
|
(13,494,180
|
)
|
|
1,717,922
|
|
||||
|
Other income and expense:
|
|
|
|
|
|
|
|
||||||||
|
Interest income
|
300,690
|
|
|
357,581
|
|
|
829,028
|
|
|
986,888
|
|
||||
|
Other income net
|
148,845
|
|
|
190,453
|
|
|
290,114
|
|
|
190,212
|
|
||||
|
Foreign currency transaction (losses) gains
|
(525,674
|
)
|
|
1,012,555
|
|
|
(656,334
|
)
|
|
374,519
|
|
||||
|
Gain on sale of investments
|
—
|
|
|
—
|
|
|
856,170
|
|
|
368,641
|
|
||||
|
Loss on investment in Ikanos
|
(557,594
|
)
|
|
—
|
|
|
(557,594
|
)
|
|
—
|
|
||||
|
Impairment of marketable debt securities
|
—
|
|
|
(150,644
|
)
|
|
—
|
|
|
(150,644
|
)
|
||||
|
Gain on sale of patents
|
—
|
|
|
—
|
|
|
—
|
|
|
155,658
|
|
||||
|
|
(633,733
|
)
|
|
1,409,945
|
|
|
761,384
|
|
|
1,925,274
|
|
||||
|
(Loss) income before provision for income taxes, equity losses in unconsolidated affiliates and net loss (income) attributable to noncontrolling interest
|
(6,393,508
|
)
|
|
490,017
|
|
|
(12,732,796
|
)
|
|
3,643,196
|
|
||||
|
Tax provision
|
(470,500
|
)
|
|
(97,500
|
)
|
|
(1,335,500
|
)
|
|
(293,000
|
)
|
||||
|
(Loss) income before equity losses in unconsolidated affiliates and net (loss) income of noncontrolling interest
|
(6,864,008
|
)
|
|
392,517
|
|
|
(14,068,296
|
)
|
|
3,350,196
|
|
||||
|
Equity losses in unconsolidated affiliates
|
(202,278
|
)
|
|
(49,596
|
)
|
|
(592,480
|
)
|
|
(203,834
|
)
|
||||
|
Net (loss) income
|
(7,066,286
|
)
|
|
342,921
|
|
|
(14,660,776
|
)
|
|
3,146,362
|
|
||||
|
Net loss (income) attributable to the noncontrolling interest
|
344,274
|
|
|
(185,461
|
)
|
|
160,300
|
|
|
(118,861
|
)
|
||||
|
Net (loss) income attributable to the controlling interest
|
$
|
(6,722,012
|
)
|
|
$
|
157,460
|
|
|
$
|
(14,500,476
|
)
|
|
$
|
3,027,501
|
|
|
Net (loss) income per share
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
(0.11
|
)
|
|
$
|
0.00
|
|
|
$
|
(0.23
|
)
|
|
$
|
0.05
|
|
|
Diluted
|
$
|
(0.11
|
)
|
|
$
|
0.00
|
|
|
$
|
(0.23
|
)
|
|
$
|
0.05
|
|
|
Weighted average number of common shares
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
63,415,345
|
|
|
64,292,212
|
|
|
63,572,753
|
|
|
64,519,225
|
|
||||
|
Diluted
|
63,415,345
|
|
|
65,441,378
|
|
|
63,572,753
|
|
|
65,623,807
|
|
||||
|
|
Three Months Ended
|
|
Nine months ended
|
||||||||||||
|
|
September 29, 2012
|
|
September 24, 2011
|
|
September 29, 2012
|
|
September 24, 2011
|
||||||||
|
Net (loss) income
|
$
|
(7,066,286
|
)
|
|
$
|
342,921
|
|
|
$
|
(14,660,776
|
)
|
|
$
|
3,146,362
|
|
|
Foreign currency translation adjustments
|
1,665,381
|
|
|
(3,065,739
|
)
|
|
1,890,837
|
|
|
(1,981,067
|
)
|
||||
|
Holding gain (loss) on marketable securities
|
(150,520
|
)
|
|
(1,260,634
|
)
|
|
1,220,149
|
|
|
(1,664,944
|
)
|
||||
|
Reclassifications of gains in net (loss) income
|
(29,843
|
)
|
|
21,495
|
|
|
(574,202
|
)
|
|
(395,759
|
)
|
||||
|
Comprehensive loss
|
$
|
(5,581,268
|
)
|
|
$
|
(3,961,957
|
)
|
|
$
|
(12,123,992
|
)
|
|
$
|
(895,408
|
)
|
|
Comprehensive income attributable to the noncontrolling interest
|
59,390
|
|
|
(158,480
|
)
|
|
(141,907
|
)
|
|
(236,399
|
)
|
||||
|
Comprehensive loss attributable to controlling interest
|
$
|
(5,521,878
|
)
|
|
$
|
(4,120,437
|
)
|
|
$
|
(12,265,899
|
)
|
|
$
|
(1,131,807
|
)
|
|
|
Common Stock
|
|
Additional
Paid-in Capital
|
|
Treasury Stock
|
|
Accumulated
Other
Comprehensive Income
|
|
Accumulated Deficit
|
|
Total Kopin
Corporation
Stockholders’ Equity
|
|
Noncontrolling Interest
|
|
Total
Stockholders’ Equity
|
|||||||||||||||||||
|
|
Shares
|
|
Amount
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Balance, December 31, 2011
|
73,226,258
|
|
|
$
|
732,263
|
|
|
$
|
315,710,160
|
|
|
$
|
(30,995,449
|
)
|
|
$
|
4,146,024
|
|
|
$
|
(124,631,665
|
)
|
|
$
|
164,961,333
|
|
|
$
|
5,135,423
|
|
|
$
|
170,096,756
|
|
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
2,906,186
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,906,186
|
|
|
—
|
|
|
2,906,186
|
|
||||||||
|
Vesting of restricted stock
|
78,000
|
|
|
780
|
|
|
(780
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
Net unrealized holding gain on marketable securities
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
645,947
|
|
|
—
|
|
|
645,947
|
|
|
—
|
|
|
645,947
|
|
||||||||
|
Acquisition of Ikanos equity interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,384,039
|
|
|
1,384,039
|
|
||||||||
|
Foreign currency translation adjustments
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,588,631
|
|
|
—
|
|
|
1,588,631
|
|
|
302,206
|
|
|
1,890,837
|
|
||||||||
|
Restricted stock for tax withholdings
|
(28,823
|
)
|
|
(289
|
)
|
|
(100,387
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(100,676
|
)
|
|
—
|
|
|
(100,676
|
)
|
||||||||
|
Treasury stock purchase
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,455,529
|
)
|
|
—
|
|
|
—
|
|
|
(3,455,529
|
)
|
|
—
|
|
|
(3,455,529
|
)
|
||||||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(14,500,476
|
)
|
|
(14,500,476
|
)
|
|
(160,300
|
)
|
|
(14,660,776
|
)
|
||||||||
|
Balance, September 29, 2012
|
73,275,435
|
|
|
$
|
732,754
|
|
|
$
|
318,515,179
|
|
|
$
|
(34,450,978
|
)
|
|
$
|
6,380,602
|
|
|
$
|
(139,132,141
|
)
|
|
$
|
152,045,416
|
|
|
$
|
6,661,368
|
|
|
$
|
158,706,784
|
|
|
|
Nine months ended
|
||||||
|
|
September 29,
2012 |
|
September 24,
2011 |
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net (loss) income
|
$
|
(14,660,776
|
)
|
|
$
|
3,146,362
|
|
|
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
7,634,175
|
|
|
5,996,918
|
|
||
|
Amortization of premium or discount on marketable debt securities
|
(222,658
|
)
|
|
(110,162
|
)
|
||
|
Stock-based compensation
|
3,773,306
|
|
|
2,176,820
|
|
||
|
Net gain on sale of investments
|
(856,170
|
)
|
|
(368,641
|
)
|
||
|
Losses in unconsolidated affiliates
|
592,480
|
|
|
203,834
|
|
||
|
Impairment on investments
|
557,594
|
|
|
—
|
|
||
|
Impairment of goodwill
|
1,704,770
|
|
|
—
|
|
||
|
Deferred income tax asset
|
729,190
|
|
|
—
|
|
||
|
Foreign currency losses
|
595,016
|
|
|
(326,465
|
)
|
||
|
Impairment of marketable debt securities
|
—
|
|
|
150,644
|
|
||
|
Change in allowance for bad debt
|
(85,038
|
)
|
|
(107,726
|
)
|
||
|
Change in inventory reserves
|
668,320
|
|
|
408,900
|
|
||
|
Change in warranty reserves
|
(300,000
|
)
|
|
—
|
|
||
|
Changes in assets and liabilities:
|
|
|
|
||||
|
Accounts receivable
|
3,150,525
|
|
|
1,358,326
|
|
||
|
Inventory
|
297,273
|
|
|
2,862,935
|
|
||
|
Prepaid expenses and other current assets
|
168,068
|
|
|
721,068
|
|
||
|
Accounts payable and accrued expenses
|
(1,998,170
|
)
|
|
(4,248,968
|
)
|
||
|
Billings in excess of revenue earned
|
(252,572
|
)
|
|
(747,914
|
)
|
||
|
Net cash provided by operating activities
|
1,495,333
|
|
|
11,115,931
|
|
||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Proceeds from sale of marketable debt securities
|
33,315,471
|
|
|
36,872,779
|
|
||
|
Purchase of marketable debt securities
|
(39,706,955
|
)
|
|
(38,976,135
|
)
|
||
|
Cash paid to acquire Ikanos, net of cash acquired
|
93,872
|
|
|
—
|
|
||
|
Cash paid to acquire FDD, net of cash acquired
|
94,351
|
|
|
(10,084,307
|
)
|
||
|
Purchase of investments
|
(2,249,784
|
)
|
|
—
|
|
||
|
Proceeds from sale of investments
|
856,170
|
|
|
392,196
|
|
||
|
Other assets
|
77,383
|
|
|
32,919
|
|
||
|
Capital expenditures
|
(8,464,076
|
)
|
|
(5,730,749
|
)
|
||
|
Net cash used in investing activities
|
(15,983,568
|
)
|
|
(17,493,297
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Treasury stock purchases
|
(3,455,529
|
)
|
|
(3,060,156
|
)
|
||
|
Proceeds from exercise of stock options
|
—
|
|
|
72,445
|
|
||
|
Settlements of restricted stock for tax withholding obligations
|
(100,676
|
)
|
|
(72,374
|
)
|
||
|
Net cash used in financing activities
|
(3,556,205
|
)
|
|
(3,060,085
|
)
|
||
|
Effect of exchange rate changes on cash
|
212,516
|
|
|
(233,754
|
)
|
||
|
Net decrease in cash and equivalents
|
(17,831,924
|
)
|
|
(9,671,205
|
)
|
||
|
Cash and equivalents:
|
|
|
|
||||
|
Beginning of period
|
43,095,163
|
|
|
49,834,547
|
|
||
|
End of period
|
$
|
25,263,239
|
|
|
$
|
40,163,342
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
||||
|
Income taxes paid
|
$
|
197,000
|
|
|
$
|
163,000
|
|
|
Supplemental schedule of noncash investing activities:
|
|
|
|
||||
|
Construction in progress included in accrued expenses
|
$
|
—
|
|
|
$
|
526,000
|
|
|
|
Three months ended September 24, 2011
|
|
Nine months ended September 24, 2011
|
||||||||||||||||||||
|
|
As previously
reported |
|
Adjustment
|
|
As
restated |
|
As previously
reported |
|
Adjustment
|
|
As
restated |
||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net product revenues
|
$
|
28,512
|
|
|
$
|
—
|
|
|
$
|
28,512
|
|
|
$
|
91,031
|
|
|
$
|
—
|
|
|
$
|
91,031
|
|
|
Research and development revenues
|
1,054
|
|
|
—
|
|
|
1,054
|
|
|
4,901
|
|
|
—
|
|
|
4,901
|
|
||||||
|
Total revenues
|
29,566
|
|
|
—
|
|
|
29,566
|
|
|
95,932
|
|
|
—
|
|
|
95,932
|
|
||||||
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Cost of product revenues
|
19,046
|
|
|
707
|
|
|
19,753
|
|
|
60,107
|
|
|
707
|
|
|
60,814
|
|
||||||
|
Research and development
|
6,381
|
|
|
—
|
|
|
6,381
|
|
|
19,905
|
|
|
—
|
|
|
19,905
|
|
||||||
|
Selling, general and administrative
|
4,352
|
|
|
—
|
|
|
4,352
|
|
|
13,495
|
|
|
—
|
|
|
13,495
|
|
||||||
|
|
29,779
|
|
|
707
|
|
|
30,486
|
|
|
93,507
|
|
|
707
|
|
|
94,214
|
|
||||||
|
(Loss) income from operations
|
(213
|
)
|
|
(707
|
)
|
|
(920
|
)
|
|
2,425
|
|
|
(707
|
)
|
|
1,718
|
|
||||||
|
Other income and expense:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Interest income
|
358
|
|
|
—
|
|
|
358
|
|
|
987
|
|
|
—
|
|
|
987
|
|
||||||
|
Other income net
|
190
|
|
|
—
|
|
|
190
|
|
|
190
|
|
|
—
|
|
|
190
|
|
||||||
|
Foreign currency gains
|
1,013
|
|
|
—
|
|
|
1,013
|
|
|
375
|
|
|
—
|
|
|
375
|
|
||||||
|
Gain of sale of investments
|
—
|
|
|
—
|
|
|
—
|
|
|
369
|
|
|
—
|
|
|
369
|
|
||||||
|
Impairment of marketable debt securities
|
(151
|
)
|
|
—
|
|
|
(151
|
)
|
|
(151
|
)
|
|
—
|
|
|
(151
|
)
|
||||||
|
Gain on sale of patents
|
—
|
|
|
—
|
|
|
—
|
|
|
156
|
|
|
—
|
|
|
156
|
|
||||||
|
|
1,410
|
|
|
—
|
|
|
1,410
|
|
|
1,926
|
|
|
—
|
|
|
1,926
|
|
||||||
|
Income (loss) before provision for income taxes, equity losses in unconsolidated affiliates and net income (loss) of noncontrolling interest
|
1,197
|
|
|
(707
|
)
|
|
490
|
|
|
4,351
|
|
|
(707
|
)
|
|
3,644
|
|
||||||
|
Tax provision
|
(98
|
)
|
|
—
|
|
|
(98
|
)
|
|
(293
|
)
|
|
—
|
|
|
(293
|
)
|
||||||
|
Income (loss) before equity losses in unconsolidated affiliates and net income (loss) of noncontrolling interest
|
1,099
|
|
|
(707
|
)
|
|
392
|
|
|
4,058
|
|
|
(707
|
)
|
|
3,351
|
|
||||||
|
Equity losses in unconsolidated affiliates
|
(50
|
)
|
|
—
|
|
|
(50
|
)
|
|
(204
|
)
|
|
—
|
|
|
(204
|
)
|
||||||
|
Net income (loss)
|
1,049
|
|
|
(707
|
)
|
|
342
|
|
|
3,854
|
|
|
(707
|
)
|
|
3,147
|
|
||||||
|
Net (income) loss attributable to the noncontrolling interest
|
(254
|
)
|
|
69
|
|
|
(185
|
)
|
|
(188
|
)
|
|
69
|
|
|
(119
|
)
|
||||||
|
Net income (loss) attributable to the controlling interest
|
$
|
795
|
|
|
$
|
(638
|
)
|
|
$
|
157
|
|
|
$
|
3,666
|
|
|
$
|
(638
|
)
|
|
$
|
3,028
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Basic
|
$
|
0.01
|
|
|
$
|
(0.01
|
)
|
|
$
|
0.00
|
|
|
$
|
0.06
|
|
|
$
|
(0.01
|
)
|
|
$
|
0.05
|
|
|
Diluted
|
$
|
0.01
|
|
|
$
|
(0.01
|
)
|
|
$
|
0.00
|
|
|
$
|
0.06
|
|
|
$
|
(0.01
|
)
|
|
$
|
0.05
|
|
|
Weighted average number of common shares:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Basic
|
64,292
|
|
|
|
|
64,292
|
|
|
64,519
|
|
|
|
|
64,519
|
|
||||||||
|
Diluted
|
65,441
|
|
|
|
|
65,441
|
|
|
65,624
|
|
|
|
|
65,624
|
|
||||||||
|
|
December 31, 2011 as previously reported
|
|
|
|
December 31, 2011 as restated
|
||||||
|
|
|
Adjustment
|
|
||||||||
|
ASSETS
|
|
|
|
|
|
||||||
|
Current assets:
|
|
|
|
|
|
||||||
|
Cash and equivalents
|
$
|
43,095
|
|
|
$
|
—
|
|
|
$
|
43,095
|
|
|
Marketable debt securities, at fair value
|
62,323
|
|
|
—
|
|
|
62,323
|
|
|||
|
Accounts receivable, net of allowance of $513,000 in 2011
|
16,511
|
|
|
—
|
|
|
16,511
|
|
|||
|
Accounts receivable from unconsolidated affiliates
|
1,341
|
|
|
—
|
|
|
1,341
|
|
|||
|
Unbilled receivable
|
36
|
|
|
—
|
|
|
36
|
|
|||
|
Inventory
|
21,416
|
|
|
(947
|
)
|
|
20,469
|
|
|||
|
Prepaid taxes
|
412
|
|
|
256
|
|
|
668
|
|
|||
|
Prepaid expenses and other current assets
|
1,294
|
|
|
—
|
|
|
1,294
|
|
|||
|
Total current assets
|
146,428
|
|
|
(691
|
)
|
|
145,737
|
|
|||
|
Property, plant & equipment, net
|
32,369
|
|
|
—
|
|
|
32,369
|
|
|||
|
Deferred tax assets
|
4,202
|
|
|
—
|
|
|
4,202
|
|
|||
|
Goodwill
|
1,665
|
|
|
—
|
|
|
1,665
|
|
|||
|
Intangible assets
|
1,954
|
|
|
—
|
|
|
1,954
|
|
|||
|
Other assets
|
7,946
|
|
|
—
|
|
|
7,946
|
|
|||
|
Total assets
|
$
|
194,564
|
|
|
$
|
(691
|
)
|
|
$
|
193,873
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||||||
|
Current Liabilities:
|
|
|
|
|
|
||||||
|
Accounts payable
|
$
|
12,385
|
|
|
$
|
—
|
|
|
$
|
12,385
|
|
|
Accrued payroll and expenses
|
4,183
|
|
|
—
|
|
|
4,183
|
|
|||
|
Accrued warranty
|
1,318
|
|
|
—
|
|
|
1,318
|
|
|||
|
Billings in excess of revenue earned
|
2,467
|
|
|
—
|
|
|
2,467
|
|
|||
|
Other accrued liabilities
|
2,127
|
|
|
—
|
|
|
2,127
|
|
|||
|
Total current liabilities
|
22,480
|
|
|
—
|
|
|
22,480
|
|
|||
|
Asset Retirement obligations
|
1,296
|
|
|
—
|
|
|
1,296
|
|
|||
|
Commitments and contingencies
|
|
|
|
|
|
|
|||||
|
Stockholders’ equity:
|
|
|
|
|
|
||||||
|
Preferred stock
|
|
|
|
|
—
|
|
|||||
|
Common stock
|
732
|
|
|
—
|
|
|
732
|
|
|||
|
Additional paid-in capital
|
315,710
|
|
|
—
|
|
|
315,710
|
|
|||
|
Treasury stock
|
(30,995
|
)
|
|
—
|
|
|
(30,995
|
)
|
|||
|
Accumulated other comprehensive income
|
4,146
|
|
|
—
|
|
|
4,146
|
|
|||
|
Accumulated deficit
|
(124,008
|
)
|
|
(623
|
)
|
|
(124,631
|
)
|
|||
|
Total Kopin Corporation stockholders’ equity
|
165,585
|
|
|
(623
|
)
|
|
164,962
|
|
|||
|
Non controlling interest
|
5,203
|
|
|
(68
|
)
|
|
5,135
|
|
|||
|
Total stockholder’ equity
|
170,788
|
|
|
(691
|
)
|
|
170,097
|
|
|||
|
Total liabilities and stockholders’ equity
|
$
|
194,564
|
|
|
$
|
(691
|
)
|
|
$
|
193,873
|
|
|
|
Amortized Cost
|
|
Unrealized Gains
|
|
Unrealized Losses
|
|
Fair Value
|
||||||||||||||||||||||||
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||||||||||
|
U.S. government and agency backed securities
|
$
|
38,104,940
|
|
|
$
|
31,480,482
|
|
|
$
|
580,067
|
|
|
$
|
665,171
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
38,685,007
|
|
|
$
|
32,145,653
|
|
|
Corporate debt and certificates of deposit
|
30,995,263
|
|
|
30,879,717
|
|
|
—
|
|
|
—
|
|
|
(406,274
|
)
|
|
(701,983
|
)
|
|
30,588,989
|
|
|
30,177,734
|
|
||||||||
|
Total
|
$
|
69,100,203
|
|
|
$
|
62,360,199
|
|
|
$
|
580,067
|
|
|
$
|
665,171
|
|
|
$
|
(406,274
|
)
|
|
$
|
(701,983
|
)
|
|
$
|
69,273,996
|
|
|
$
|
62,323,387
|
|
|
|
Less than
One year
|
|
One to
Five years
|
|
Greater than
Five years
|
|
Total
|
||||||||
|
U.S. government and agency backed securities
|
$
|
11,039,060
|
|
|
$
|
21,216,761
|
|
|
$
|
6,429,186
|
|
|
$
|
38,685,007
|
|
|
Corporate debt and certificates of deposit
|
20,550,637
|
|
|
9,137,102
|
|
|
901,250
|
|
|
30,588,989
|
|
||||
|
Total
|
$
|
31,589,697
|
|
|
$
|
30,353,863
|
|
|
$
|
7,330,436
|
|
|
$
|
69,273,996
|
|
|
|
|
|
Fair Value Measurement at September 29, 2012 Using:
|
||||||||||||
|
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
|
Money Markets, Cash and Equivalents
|
$
|
25,263,239
|
|
|
$
|
25,263,239
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
U.S. Government Securities
|
38,685,007
|
|
|
17,589,512
|
|
|
21,095,495
|
|
|
—
|
|
||||
|
Corporate Debt
|
11,955,688
|
|
|
—
|
|
|
11,955,688
|
|
|
—
|
|
||||
|
Certificates of Deposit
|
18,633,301
|
|
|
—
|
|
|
18,633,301
|
|
|
—
|
|
||||
|
WIN Semiconductor Corp.
|
1,568,673
|
|
|
1,568,673
|
|
|
—
|
|
|
—
|
|
||||
|
Advanced Wireless Semiconductor Company
|
2,177,955
|
|
|
2,177,955
|
|
|
—
|
|
|
—
|
|
||||
|
|
$
|
98,283,863
|
|
|
$
|
46,599,379
|
|
|
$
|
51,684,484
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
Fair Value Measurement at December 31, 2011 Using:
|
||||||||||||
|
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
|
Money Markets, Cash and Equivalents
|
$
|
43,095,163
|
|
|
$
|
43,095,163
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
U.S. Government Securities
|
32,145,653
|
|
|
12,892,670
|
|
|
19,252,983
|
|
|
—
|
|
||||
|
Corporate Debt
|
18,754,992
|
|
|
—
|
|
|
18,754,992
|
|
|
—
|
|
||||
|
Certificates of Deposit
|
11,422,742
|
|
|
—
|
|
|
11,422,742
|
|
|
—
|
|
||||
|
WIN Semiconductor Corp.
|
1,709,189
|
|
|
1,709,189
|
|
|
—
|
|
|
—
|
|
||||
|
Advanced Wireless Semiconductor Company
|
1,602,096
|
|
|
1,602,096
|
|
|
—
|
|
|
—
|
|
||||
|
|
$
|
108,729,835
|
|
|
$
|
59,299,118
|
|
|
$
|
49,430,717
|
|
|
$
|
—
|
|
|
|
September 29,
2012 |
|
December 31,
2011 |
||||
|
Raw materials
|
$
|
9,698,862
|
|
|
$
|
9,934,724
|
|
|
Work-in-process
|
3,206,065
|
|
|
5,220,353
|
|
||
|
Finished goods
|
6,780,062
|
|
|
5,313,435
|
|
||
|
|
$
|
19,684,989
|
|
|
$
|
20,468,512
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
|
September 29, 2012
|
|
September 24,
2011 |
|
September 29,
2012 |
|
September 24,
2011 |
||||
|
Weighted average common shares outstanding-basic
|
63,415,345
|
|
|
64,292,212
|
|
|
63,572,753
|
|
|
64,519,225
|
|
|
Stock options and non-vested restricted common stock
|
—
|
|
|
1,149,166
|
|
|
—
|
|
|
1,104,582
|
|
|
Weighted average common shares outstanding-diluted
|
63,415,345
|
|
|
65,441,378
|
|
|
63,572,753
|
|
|
65,623,807
|
|
|
|
September 29, 2012
|
|
September 24, 2011
|
||
|
Non-vested restricted common stock
|
2,881,116
|
|
|
879,012
|
|
|
Stock options
|
1,838,345
|
|
|
1,583,550
|
|
|
Total
|
4,719,461
|
|
|
2,462,562
|
|
|
|
Nine months ended September 29, 2012
|
|||||
|
|
Shares
|
|
Weighted
Average Exercise Price |
|||
|
Balance, December 31, 2011
|
1,903,325
|
|
|
$
|
5.07
|
|
|
Options forfeited/cancelled
|
(64,980
|
)
|
|
7.98
|
|
|
|
Options exercised
|
—
|
|
|
—
|
|
|
|
Balance, all exercisable, September 29, 2012
|
1,838,345
|
|
|
$
|
4.97
|
|
|
|
Options Outstanding and Exercisable
|
||||||||
|
Range of Exercise Prices
|
Number
Outstanding and Exercisable |
|
Weighted
Average Remaining Contractual Life (Years) |
|
Weighted
Average Exercise Price |
||||
|
$ 0.01—$ 3.50
|
130,000
|
|
|
4.00
|
|
$
|
3.49
|
|
|
|
$ 3.75—$ 4.82
|
1,069,340
|
|
|
1.60
|
|
4.45
|
|
||
|
$ 5.00—$ 8.03
|
539,005
|
|
|
2.23
|
|
5.40
|
|
||
|
$10.00—$10.00
|
100,000
|
|
|
4.00
|
|
10.00
|
|
||
|
|
1,838,345
|
|
|
2.09
|
|
$
|
4.97
|
|
|
|
Aggregate intrinsic value on September 29, 2012
|
$
|
37,641
|
|
|
|
|
|
||
|
|
Shares
|
|
Weighted
Average Grant Fair Value |
|||
|
Balance, December 31, 2011
|
2,897,682
|
|
|
$
|
4.20
|
|
|
Granted
|
85,000
|
|
|
3.60
|
|
|
|
Forfeited
|
(23,566
|
)
|
|
4.36
|
|
|
|
Vested
|
(78,000
|
)
|
|
3.54
|
|
|
|
Balance, September 29, 2012
|
2,881,116
|
|
|
$
|
4.20
|
|
|
|
Nine Months Ended
|
||||||
|
|
September 29,
2012 |
|
September 24,
2011 |
||||
|
Cost of product revenues
|
$
|
390,702
|
|
|
$
|
432,816
|
|
|
Research and development
|
271,297
|
|
|
417,698
|
|
||
|
Selling, general and administrative
|
3,111,307
|
|
|
1,326,306
|
|
||
|
Total
|
$
|
3,773,306
|
|
|
$
|
2,176,820
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 29,
2012 |
|
September 24,
2011 |
|
September 29,
2012 |
|
September 24,
2011 |
||||||||
|
Revenue
|
$
|
1,599,000
|
|
|
$
|
2,883,000
|
|
|
$
|
4,517,000
|
|
|
$
|
5,172,000
|
|
|
Gross margin
|
(1,343,000
|
)
|
|
(52,000
|
)
|
|
(2,228,000
|
)
|
|
(451,000
|
)
|
||||
|
Loss from operations
|
(1,751,000
|
)
|
|
(595,000
|
)
|
|
(4,034,000
|
)
|
|
(1,849,000
|
)
|
||||
|
Net loss
|
$
|
(1,723,000
|
)
|
|
$
|
(423,000
|
)
|
|
$
|
(4,566,000
|
)
|
|
$
|
(1,737,000
|
)
|
|
Cash consideration
|
$
|
2,500,000
|
|
|
Fair market value of Kopin's previously held equity method investment in Ikanos
|
81,000
|
|
|
|
Total purchase price
|
$
|
2,581,000
|
|
|
Cash and equivalents
|
$
|
2,594,000
|
|
|
Accounts receivable
|
167,000
|
|
|
|
Property, plant and equipment
|
277,000
|
|
|
|
Goodwill
|
1,141,000
|
|
|
|
Other identifiable assets
|
111,000
|
|
|
|
Identifiable liabilities
|
(325,000
|
)
|
|
|
Noncontrolling interest in Ikanos
|
(1,384,000
|
)
|
|
|
Total
|
$
|
2,581,000
|
|
|
|
Nine Months
Ended
September 29,
|
|
Nine Months
Ended
September 24,
|
||||
|
|
2012
|
|
2011
|
||||
|
Revenues
|
$
|
70,120,000
|
|
|
$
|
96,566,000
|
|
|
Net (loss) income
|
(15,484,000
|
)
|
|
3,068,000
|
|
||
|
|
|
||
|
Goodwill, December 31, 2011
|
$
|
1,664,457
|
|
|
Acquisition of Ikanos
|
1,140,787
|
|
|
|
Impairment of goodwill
|
(1,704,770
|
)
|
|
|
Foreign currency translation
|
40,313
|
|
|
|
Goodwill, September 29, 2012
|
$
|
1,140,787
|
|
|
|
|
|
|
Years
|
|
Customer relationships
|
7
|
|
Developed technology
|
7
|
|
Trademark portfolio
|
7
|
|
|
|
||
|
Beginning Balance, December 31, 2011
|
$
|
1,318,000
|
|
|
Additions
|
1,544,000
|
|
|
|
Claim and reversals
|
(1,847,000
|
)
|
|
|
Ending Balance, September 29, 2012
|
$
|
1,015,000
|
|
|
|
Kopin U.S.
|
|
Kowon
|
|
KTC
|
|
FDD
|
|
Adjustments
|
|
Total
|
||||||||||||
|
Three Months Ended
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
September 29, 2012
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Revenues
|
$
|
21,224
|
|
|
$
|
1,415
|
|
|
$
|
7,429
|
|
|
$
|
716
|
|
|
$
|
(8,844
|
)
|
|
$
|
21,940
|
|
|
Net (loss) income attributable to the controlling interest
|
(7,349
|
)
|
|
(465
|
)
|
|
1,230
|
|
|
(482
|
)
|
|
344
|
|
|
(6,722
|
)
|
||||||
|
September 24, 2011
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Revenues
|
$
|
28,038
|
|
|
$
|
2,734
|
|
|
$
|
5,892
|
|
|
$
|
1,492
|
|
|
$
|
(8,590
|
)
|
|
$
|
29,566
|
|
|
Net income (loss) attributable to the controlling interest
|
2
|
|
|
797
|
|
|
135
|
|
|
(593
|
)
|
|
(184
|
)
|
|
157
|
|
||||||
|
Nine Months Ended
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
September 29, 2012
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Revenues
|
$
|
68,124
|
|
|
$
|
4,193
|
|
|
$
|
24,907
|
|
|
$
|
1,912
|
|
|
$
|
(29,100
|
)
|
|
$
|
70,036
|
|
|
Net (loss) income attributable to the controlling interest
|
(14,387
|
)
|
|
(639
|
)
|
|
3,894
|
|
|
(3,528
|
)
|
|
160
|
|
|
(14,500
|
)
|
||||||
|
September 24, 2011
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Revenues
|
$
|
91,838
|
|
|
$
|
7,927
|
|
|
$
|
12,232
|
|
|
$
|
4,014
|
|
|
$
|
(20,079
|
)
|
|
$
|
95,932
|
|
|
Net income (loss) attributable to the controlling interest
|
3,707
|
|
|
305
|
|
|
627
|
|
|
(1,492
|
)
|
|
(119
|
)
|
|
3,028
|
|
||||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
|
September 29, 2012
|
|
September 24, 2011
|
|
September 29, 2012
|
|
September 24, 2011
|
||||
|
Asia-Pacific
|
26
|
%
|
|
19
|
%
|
|
22
|
%
|
|
21
|
%
|
|
Americas
|
72
|
%
|
|
79
|
%
|
|
76
|
%
|
|
78
|
%
|
|
Europe
|
2
|
%
|
|
2
|
%
|
|
2
|
%
|
|
1
|
%
|
|
Total Revenues
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 29, 2012
|
|
September 24, 2011
|
|
September 29, 2012
|
|
September 24, 2011
|
||||||||
|
Display
|
$
|
8,190,000
|
|
|
$
|
14,063,000
|
|
|
$
|
26,068,000
|
|
|
$
|
46,861,000
|
|
|
III-V
|
13,750,000
|
|
|
15,503,000
|
|
|
43,968,000
|
|
|
49,071,000
|
|
||||
|
Total Revenues
|
$
|
21,940,000
|
|
|
$
|
29,566,000
|
|
|
$
|
70,036,000
|
|
|
$
|
95,932,000
|
|
|
Item 2:
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
Revenues (in millions):
|
September 29, 2012
|
|
September 24, 2011
|
|
September 29, 2012
|
|
September 24, 2011
|
||||||||
|
Display
|
$
|
8.2
|
|
|
$
|
14.1
|
|
|
$
|
26.0
|
|
|
$
|
46.8
|
|
|
III-V
|
13.7
|
|
|
15.5
|
|
|
44.0
|
|
|
49.1
|
|
||||
|
Total revenues
|
$
|
21.9
|
|
|
$
|
29.6
|
|
|
$
|
70.0
|
|
|
$
|
95.9
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
Display Revenues by Category (in millions )
|
September 29, 2012
|
|
September 24, 2011
|
|
September 29, 2012
|
|
September 24, 2011
|
||||||||
|
Military Application
|
$
|
4.3
|
|
|
$
|
7.3
|
|
|
$
|
15.0
|
|
|
$
|
27.5
|
|
|
Consumer Electronic Applications
|
3.0
|
|
|
5.8
|
|
|
8.8
|
|
|
14.7
|
|
||||
|
Research & Development
|
0.9
|
|
|
1.0
|
|
|
2.2
|
|
|
4.6
|
|
||||
|
Total
|
$
|
8.2
|
|
|
$
|
14.1
|
|
|
$
|
26.0
|
|
|
$
|
46.8
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
Cost of product revenues:
|
September 29, 2012
|
|
September 24, 2011
|
|
September 29, 2012
|
|
September 24, 2011
|
||||||||
|
Cost of product revenues (in millions):
|
$
|
15.8
|
|
|
$
|
19.8
|
|
|
$
|
49.7
|
|
|
$
|
60.8
|
|
|
Cost of product revenues as a % of net product revenues
|
75.4
|
%
|
|
69.3
|
%
|
|
73.7
|
%
|
|
66.8
|
%
|
||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
Research and development expense (in millions):
|
September 29, 2012
|
|
September 24, 2011
|
|
September 29, 2012
|
|
September 24, 2011
|
||||||||
|
Funded
|
$
|
0.6
|
|
|
$
|
0.8
|
|
|
$
|
1.6
|
|
|
$
|
3.3
|
|
|
Internal
|
5.8
|
|
|
5.6
|
|
|
14.9
|
|
|
16.6
|
|
||||
|
Total research and development expense
|
$
|
6.4
|
|
|
$
|
6.4
|
|
|
$
|
16.5
|
|
|
$
|
19.9
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 29, 2012
|
|
September 24, 2011
|
|
September 29, 2012
|
|
September 24, 2011
|
||||||||
|
Selling, general and administration expense (in millions):
|
$
|
5.5
|
|
|
$
|
4.4
|
|
|
$
|
15.6
|
|
|
$
|
13.5
|
|
|
Selling, general and administration expense as a % of revenues
|
24.9
|
%
|
|
14.7
|
%
|
|
22.3
|
%
|
|
14.1
|
%
|
||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 29, 2012
|
|
September 24, 2011
|
|
September 29, 2012
|
|
September 24, 2011
|
||||||||
|
Other income and expense (in millions):
|
$
|
(0.6
|
)
|
|
$
|
1.4
|
|
|
$
|
0.8
|
|
|
$
|
1.9
|
|
|
|
|
||
|
Domestic
|
$
|
75,643,686
|
|
|
Foreign
|
14,461,671
|
|
|
|
Subtotal cash and marketable debt securities
|
90,105,357
|
|
|
|
Cash and marketable debt securities held in other currencies and converted to U.S. dollars
|
4,431,878
|
|
|
|
Total cash and marketable debt securities
|
$
|
94,537,235
|
|
|
Contractual Obligations
|
Total
|
|
Less than 1 year
|
|
1-3 Years
|
|
3-5 years
|
|
More than 5 years
|
||||||||||
|
Operating Lease Obligations
|
$
|
11,014,268
|
|
|
$
|
1,280,827
|
|
|
$
|
3,485,056
|
|
|
$
|
3,627,625
|
|
|
$
|
2,620,760
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
|
Item 4.
|
Controls and Procedures
|
|
Item 1.
|
Legal Proceedings
|
|
Item 1A.
|
Risk Factors
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
Item 5.
|
Other Information
|
|
|
Three months ended March 31, 2012
|
||||||||||
|
|
As previously
reported
|
|
Adjustment
|
|
As
restated
|
||||||
|
Revenues:
|
|
|
|
|
|
||||||
|
Net product revenues
|
$
|
24,655
|
|
|
$
|
—
|
|
|
$
|
24,655
|
|
|
Research and development revenues
|
593
|
|
|
—
|
|
|
593
|
|
|||
|
Total revenues
|
25,248
|
|
|
—
|
|
|
25,248
|
|
|||
|
Expenses:
|
|
|
|
|
|
||||||
|
Cost of product revenues
|
17,398
|
|
|
562
|
|
|
17,960
|
|
|||
|
Research and development
|
5,129
|
|
|
—
|
|
|
5,129
|
|
|||
|
Selling, general and administration
|
5,098
|
|
|
—
|
|
|
5,098
|
|
|||
|
|
27,625
|
|
|
562
|
|
|
28,187
|
|
|||
|
Loss from operations
|
(2,377
|
)
|
|
(562
|
)
|
|
(2,939
|
)
|
|||
|
Other income and expense:
|
|
|
|
|
|
||||||
|
Interest income
|
234
|
|
|
—
|
|
|
234
|
|
|||
|
Other income net
|
53
|
|
|
—
|
|
|
53
|
|
|||
|
Foreign currency losses
|
(198
|
)
|
|
—
|
|
|
(198
|
)
|
|||
|
Gain of sale of investments
|
856
|
|
|
—
|
|
|
856
|
|
|||
|
|
945
|
|
|
—
|
|
|
945
|
|
|||
|
Loss before (provision) benefit for income taxes, equity losses in unconsolidated affiliates and net (income) loss of noncontrolling interest
|
(1,432
|
)
|
|
(562
|
)
|
|
(1,994
|
)
|
|||
|
Tax (provision) benefit
|
(468
|
)
|
|
152
|
|
|
(316
|
)
|
|||
|
Loss before equity losses in unconsolidated affiliates and net (income) loss of noncontrolling interest
|
(1,900
|
)
|
|
(410
|
)
|
|
(2,310
|
)
|
|||
|
Equity losses in unconsolidated affiliates
|
(156
|
)
|
|
—
|
|
|
(156
|
)
|
|||
|
Net loss
|
(2,056
|
)
|
|
(410
|
)
|
|
(2,466
|
)
|
|||
|
Net (income) loss attributable to the noncontrolling interest
|
(152
|
)
|
|
40
|
|
|
(112
|
)
|
|||
|
Net loss attributable to the controlling interest
|
$
|
(2,208
|
)
|
|
$
|
(370
|
)
|
|
$
|
(2,578
|
)
|
|
Net loss per share:
|
|
|
|
|
|
||||||
|
Basic
|
$
|
(0.03
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
(0.04
|
)
|
|
Diluted
|
$
|
(0.03
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
(0.04
|
)
|
|
Weighted average number of common shares:
|
|
|
|
|
|
||||||
|
Basic
|
64,225
|
|
|
|
|
64,225
|
|
||||
|
Diluted
|
64,225
|
|
|
|
|
64,225
|
|
||||
|
|
Fiscal year ended December 31, 2011
|
||||||||||
|
|
As previously
reported
|
|
Adjustment
|
|
As
restated
|
||||||
|
Revenues:
|
|
|
|
|
|
||||||
|
Net product revenues
|
$
|
125,465
|
|
|
$
|
—
|
|
|
$
|
125,465
|
|
|
Research and development revenues
|
5,680
|
|
|
—
|
|
|
5,680
|
|
|||
|
Total revenues
|
131,145
|
|
|
—
|
|
|
131,145
|
|
|||
|
Expenses:
|
|
|
|
|
|
||||||
|
Cost of product revenues
|
82,110
|
|
|
831
|
|
|
82,941
|
|
|||
|
Research and development - funded programs
|
3,742
|
|
|
—
|
|
|
3,742
|
|
|||
|
Research and development - internal
|
22,133
|
|
|
—
|
|
|
22,133
|
|
|||
|
Selling, general and administrative
|
18,929
|
|
|
—
|
|
|
18,929
|
|
|||
|
Impairment
|
5,000
|
|
|
—
|
|
|
5,000
|
|
|||
|
|
131,914
|
|
|
831
|
|
|
132,745
|
|
|||
|
Loss from operations
|
(769
|
)
|
|
(831
|
)
|
|
(1,600
|
)
|
|||
|
Other income and expense:
|
|
|
|
|
|
||||||
|
Interest income
|
1,305
|
|
|
—
|
|
|
1,305
|
|
|||
|
Other income
|
93
|
|
|
—
|
|
|
93
|
|
|||
|
Foreign currency gains
|
12
|
|
|
—
|
|
|
12
|
|
|||
|
Gain of sale of investments
|
369
|
|
|
—
|
|
|
369
|
|
|||
|
Impairment of marketable debt securities
|
(151
|
)
|
|
—
|
|
|
(151
|
)
|
|||
|
Gain on sale of patents
|
156
|
|
|
—
|
|
|
156
|
|
|||
|
|
1,784
|
|
|
—
|
|
|
1,784
|
|
|||
|
Income before benefit for income taxes, equity loss in unconsolidated affiliate and net (income) loss of noncontrolling interest
|
1,015
|
|
|
(831
|
)
|
|
184
|
|
|||
|
Tax benefit
|
3,541
|
|
|
256
|
|
|
3,797
|
|
|||
|
Income before equity loss in unconsolidated affiliate and net (income) loss of noncontrolling interest
|
4,556
|
|
|
(575
|
)
|
|
3,981
|
|
|||
|
Equity loss in unconsolidated affiliate
|
(296
|
)
|
|
—
|
|
|
(296
|
)
|
|||
|
Net income (loss)
|
4,260
|
|
|
(575
|
)
|
|
3,685
|
|
|||
|
Net (income) loss attributable to the noncontrolling interest
|
(662
|
)
|
|
57
|
|
|
(605
|
)
|
|||
|
Net income (loss) attributable to the controlling interest
|
$
|
3,598
|
|
|
$
|
(518
|
)
|
|
$
|
3,080
|
|
|
Net income (loss) per share:
|
|
|
|
|
|
||||||
|
Basic
|
$
|
0.06
|
|
|
$
|
(0.01
|
)
|
|
$
|
0.05
|
|
|
Diluted
|
$
|
0.06
|
|
|
$
|
(0.01
|
)
|
|
$
|
0.05
|
|
|
Weighted average number of common shares:
|
|
|
|
|
|
||||||
|
Basic
|
64,406
|
|
|
|
|
64,406
|
|
||||
|
Diluted
|
65,234
|
|
|
|
|
65,234
|
|
||||
|
|
Fiscal year ended December 25, 2010
|
||||||||||
|
|
As previously reported
|
|
Adjustment
|
|
As
restated
|
||||||
|
Revenues:
|
|
|
|
|
|
||||||
|
Net product revenues
|
$
|
116,623
|
|
|
$
|
—
|
|
|
$
|
116,623
|
|
|
Research and development revenues
|
3,763
|
|
|
—
|
|
|
3,763
|
|
|||
|
Total revenues
|
120,386
|
|
|
—
|
|
|
120,386
|
|
|||
|
Expenses:
|
|
|
|
|
|
||||||
|
Cost of product revenues
|
81,224
|
|
|
116
|
|
|
81,340
|
|
|||
|
Research and development - funded programs
|
2,692
|
|
|
—
|
|
|
2,692
|
|
|||
|
Research and development - internal
|
17,041
|
|
|
—
|
|
|
17,041
|
|
|||
|
Selling, general and administrative
|
14,838
|
|
|
—
|
|
|
14,838
|
|
|||
|
|
115,795
|
|
|
116
|
|
|
115,911
|
|
|||
|
Income (loss) from operations
|
4,591
|
|
|
(116
|
)
|
|
4,475
|
|
|||
|
Other income and expense:
|
|
|
|
|
|
||||||
|
Interest income
|
2,192
|
|
|
—
|
|
|
2,192
|
|
|||
|
Other income
|
77
|
|
|
—
|
|
|
77
|
|
|||
|
Foreign currency losses
|
(419
|
)
|
|
—
|
|
|
(419
|
)
|
|||
|
Gain of sale of investments
|
2,598
|
|
|
—
|
|
|
2,598
|
|
|||
|
Gain on sale of patents
|
770
|
|
|
—
|
|
|
770
|
|
|||
|
|
5,218
|
|
|
—
|
|
|
5,218
|
|
|||
|
Income before provision for income taxes, equity loss in unconsolidated affiliate and net (income) loss of noncontrolling interest
|
9,809
|
|
|
(116
|
)
|
|
9,693
|
|
|||
|
Tax provision
|
(252
|
)
|
|
—
|
|
|
(252
|
)
|
|||
|
Income before equity loss in unconsolidated affiliate and net (income) loss of noncontrolling interest
|
9,557
|
|
|
(116
|
)
|
|
9,441
|
|
|||
|
Equity loss in unconsolidated affiliate
|
(600
|
)
|
|
—
|
|
|
(600
|
)
|
|||
|
Net income (loss)
|
8,957
|
|
|
(116
|
)
|
|
8,841
|
|
|||
|
Net (income) loss attributable to the noncontrolling interest
|
(22
|
)
|
|
11
|
|
|
(11
|
)
|
|||
|
Net income (loss) attributable to the controlling interest
|
$
|
8,935
|
|
|
$
|
(105
|
)
|
|
$
|
8,830
|
|
|
Net income per share:
|
|
|
|
|
|
||||||
|
Basic
|
$
|
0.14
|
|
|
$
|
—
|
|
|
$
|
0.14
|
|
|
Diluted
|
$
|
0.13
|
|
|
$
|
—
|
|
|
$
|
0.13
|
|
|
Weighted average number of common shares:
|
|
|
|
|
|
||||||
|
Basic
|
66,020
|
|
|
|
|
66,020
|
|
||||
|
Diluted
|
66,712
|
|
|
|
|
66,712
|
|
||||
|
Item 6.
|
Exhibits
|
|
Exhibit
No.
|
|
Description
|
|
3.1
|
|
Amended and Restated Certificate of Incorporation (1)
|
|
3.2
|
|
Amendment to Certificate of Incorporation (2)
|
|
3.3
|
|
Amendment to Certificate of Incorporation (2)
|
|
3.4
|
|
Fourth Amended and Restated By-laws (3)
|
|
31.1
|
|
Certification of John C.C. Fan, Chief Executive Officer, filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).
|
|
31.2
|
|
Certification of Richard A. Sneider, Chief Financial Officer, filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).
|
|
32.1
|
|
Certification of John C.C. Fan, Chief Executive Officer, furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).
|
|
32.2
|
|
Certification of Richard A. Sneider, Chief Financial Officer, furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).
|
|
101.INS
|
|
XBRL Instance Document*
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document*
|
|
101.CAL
|
|
XBRL Taxonomy Calculation Linkbase Document*
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document*
|
|
101.LAB
|
|
XBRL Taxonomy Label Linkbase Document*
|
|
101.PRE
|
|
XBRL Taxonomy Presentation Linkbase Document*
|
|
*
|
Submitted electronically herewith
|
|
(1)
|
Filed as an exhibit to Registration Statement on Form S-1, File No. 33-57450, and incorporated herein by reference.
|
|
(2)
|
Filed as an exhibit to Quarterly Report on Form 10-Q for the quarterly period July 1, 2000 and incorporated herein by reference
|
|
(3)
|
Filed as an exhibit to Current Report on Form 8-K filed on December 12, 2008 and incorporated herein by reference.
|
|
**
|
Furnished and not filed herewith
|
|
|
|
|
KOPIN CORPORATION
(Registrant)
|
|
|
|
|
|
|
|
|
Date:
|
November 8, 2012
|
|
By:
|
/
S
/ J
OHN
C.C. F
AN
|
|
|
|
|
|
John C.C. Fan
|
|
|
|
|
|
President, Chief Executive Officer and
Chairman of the Board of Directors
|
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
Date:
|
November 8, 2012
|
|
By:
|
/
S
/ R
ICHARD
A. S
NEIDER
|
|
|
|
|
|
Richard A. Sneider
|
|
|
|
|
|
Treasurer and Chief Financial Officer
|
|
|
|
|
|
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|